Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1998-6-11
pubmed:abstractText
Parenterally administered MgSO4 is neuroprotective in standard animal models of focal cerebral ischemia and in many other paradigms of brain injury. Previous small clinical trials in stroke patients have explored the safety and tolerability of different infusion regimens. This study was undertaken to optimize the regimen for a multicenter trial.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0039-2499
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
918-23
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:9596235-Acute Disease, pubmed-meshheading:9596235-Aged, pubmed-meshheading:9596235-Anticonvulsants, pubmed-meshheading:9596235-Blood Glucose, pubmed-meshheading:9596235-Blood Pressure, pubmed-meshheading:9596235-Cerebral Hemorrhage, pubmed-meshheading:9596235-Cerebral Infarction, pubmed-meshheading:9596235-Cerebrovascular Disorders, pubmed-meshheading:9596235-Diastole, pubmed-meshheading:9596235-Double-Blind Method, pubmed-meshheading:9596235-Female, pubmed-meshheading:9596235-Heart Rate, pubmed-meshheading:9596235-Humans, pubmed-meshheading:9596235-Hypotension, pubmed-meshheading:9596235-Injections, Intravenous, pubmed-meshheading:9596235-Magnesium, pubmed-meshheading:9596235-Magnesium Sulfate, pubmed-meshheading:9596235-Male, pubmed-meshheading:9596235-Systole, pubmed-meshheading:9596235-Time Factors, pubmed-meshheading:9596235-Treatment Outcome
pubmed:year
1998
pubmed:articleTitle
Dose optimization of intravenous magnesium sulfate after acute stroke.
pubmed:affiliation
University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland. k.muir@clinmed.gk.ac.uk
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Multicenter Study